{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:58:56Z","timestamp":1786978736702,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1006\/gyno.2002.6849","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T07:20:15Z","timestamp":1041060015000},"page":"9-16","source":"Crossref","is-referenced-by-count":93,"title":["Quality of Life in Women Treated with Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Prospective Longitudinal Study"],"prefix":"10.1006","volume":"88","author":[{"given":"Y.M.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.Y.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hextan Y.S.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2002.6849_RF1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9378(96)70331-9","article-title":"Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial","volume":"174","author":"Van Dam","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6849_RF3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0090-8258(85)90141-6","article-title":"Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma","volume":"20","author":"Chen","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF4","first-page":"168","article-title":"Morbidity and mortality associated with primary and repeat operations for ovarian cancer","volume":"79","author":"Venesmaa","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6849_RF5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0090-8258(90)90277-R","article-title":"Primary surgical therapy of ovarian cancer: how much and when","volume":"40","author":"Potter","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/gyno.2001.6375","article-title":"The effect of bowel resection on survival in advanced epithelial ovarian cancer","volume":"83","author":"Jaeger","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0002-9378(92)91658-W","article-title":"Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?","volume":"166","author":"Hunter","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6849_RF9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6849_RF10","first-page":"61","article-title":"Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer","volume":"73","author":"Lawton","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2002.6849_RF11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0090-8258(90)90361-N","article-title":"Neoadjuvant chemotherapy in stage X ovarian carcinoma","volume":"37","author":"Chambers","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(91)90335-3","article-title":"Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer","volume":"42","author":"Jacob","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.1994.1083","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer","volume":"53","author":"Schwartz","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival","volume":"72","author":"Schwartz","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1525-1438.1996.06050356.x","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer","volume":"6","author":"Surwit","year":"1996","journal-title":"Int J Gynecol Cancer"},{"key":"10.1006\/gyno.2002.6849_RF17","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U","article-title":"Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study","volume":"91","author":"Ansquer","year":"2001","journal-title":"Cancer"},{"key":"10.1006\/gyno.2002.6849_RF18","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#","article-title":"Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIc ovarian carcinoma","volume":"92","author":"Kuhn","year":"2001","journal-title":"Cancer"},{"key":"10.1006\/gyno.2002.6849_RF19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6849_RF20","first-page":"221","article-title":"A randomized study of high-dose versus low-dose cis-platinum combined with cyclophosphamide in the treatment of advanced ovarian cancer","volume":"35","author":"Ngan","year":"1989","journal-title":"Hong Kong Ovarian Carcinoma Study Group. Chemotherapy"},{"key":"10.1006\/gyno.2002.6849_RF21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2002.6849_RF22","series-title":"Quality of life and pharmacoeconomics in clinical trials","first-page":"179","article-title":"The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update","author":"Aaronson","year":"1995"},{"key":"10.1006\/gyno.2002.6849_RF23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00434800","article-title":"The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules","volume":"2","author":"Sprangers","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1006\/gyno.2002.6849_RF24","series-title":"EORTC QLQ-C30 scoring manual","author":"Fayers","year":"1999"},{"key":"10.1006\/gyno.2002.6849_RF25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.2001.6345","article-title":"A longitudinal study on quality of life after gynecologic cancer treatment","volume":"83","author":"Chan","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6849_RF26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Eng J Med"},{"key":"10.1006\/gyno.2002.6849_RF27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802968496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802968496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T16:21:14Z","timestamp":1553962874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825802968496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0090825802968496"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2002.6849","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}